Status:
RECRUITING
The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery
Lead Sponsor:
University of Michigan
Conditions:
Facial Defect
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Antibiotics are sometimes prescribed to patients who have had reconstructive surgery of wounds on their face using skin grafts. But, it is not yet known whether antibiotics improve the healing of skin...
Eligibility Criteria
Inclusion
- all adult patients with a nasal or facial skin/soft tissue defect requiring reconstruction limited to or including a full-thickness skin graft
Exclusion
- current or recent (within one week of surgery) systemic antibiotic use, intolerance to both clindamycin and cephalexin, discovery of a persistent cutaneous malignancy at the site of the defect following the reconstructive procedure and previous reconstruction at the site of the skin/soft-tissue defect.
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01912651
Start Date
July 1 2013
End Date
September 1 2028
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109